Details for Patent: 11,369,566

Which drugs does patent 11,369,566 protect, and when does it expire?

Patent 11,369,566 protects OTIPRIO and is included in one NDA.

This patent has one hundred and thirty-seven patent family members in twenty countries.

Summary for Patent: 11,369,566

Title:	Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Abstract:	Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Inventor(s):	Jay Lichter, Andrew M. Trammel, Fabrice Piu, Qiang Ye, Luis A. Dellamary, Carl LEBEL, Jeffrey P. Harris
Assignee:	University of California San Diego UCSD , ALK Abello Inc
Application Number:	US15/710,727
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Drugs Protected by US Patent 11,369,566

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Alk Abello	OTIPRIO	ciprofloxacin	INJECTABLE, SUSPENSION;OTIC	207986-001	Dec 10, 2015		DISCN	Yes	No			Y

International Family Members for US Patent 11,369,566

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	071388
Argentina	072253
Argentina	072828